Cargando…
An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain
PURPOSE: Studies of pregabalin for the treatment of central neuropathic pain have been limited to double-blind trials of 4–17 weeks in duration. The purpose of this study was to assess the long-term safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. The efficac...
Autores principales: | Onouchi, Kenji, Koga, Hiroaki, Yokoyama, Kazumasa, Yoshiyama, Tamotsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122555/ https://www.ncbi.nlm.nih.gov/pubmed/25114584 http://dx.doi.org/10.2147/JPR.S63028 |
Ejemplares similares
-
The efficacy of pregabalin for the treatment of neuropathic pain in Japanese subjects with moderate or severe baseline pain
por: Parsons, Bruce, et al.
Publicado: (2019) -
Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007) -
Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023) -
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double‐blind placebo‐controlled trial
por: Satoh, Jo, et al.
Publicado: (2011) -
Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan
por: Taguchi, Toshihiko, et al.
Publicado: (2015)